METHODS FOR TREATING, PREVENTING AND DETECTING THE PROGNOSIS OF COLORECTAL CANCER
The present invention relates to treating cancer including colorectal cancer (CRC) by inhibiting or blocking Annexin 1. The present invention also relates to preventing CRC in a patient at high risk by inhibiting or blocking Annexin A1. The present invention also relates to reducing chemo-resistance by inhibiting or blocking Annexin A1. The present invention also relates to detecting a poor prognosis in a subject with CRC by detecting or measuring the expression level of ANXA1 and/or the level of Annexin 1 protein..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Europäisches Patentamt - (2022) vom: 07. Sept. Zur Gesamtaufnahme - year:2022 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
HAN YIPING [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2022-09-07, Last update posted on www.tib.eu: 2022-10-25, Last updated: 2023-02-09 |
---|
Patentnummer: |
EP3796933 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA011486600 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA011486600 | ||
003 | DE-627 | ||
005 | 20230504130016.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210601s2022 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA011486600 | ||
035 | |a (EPA)EP3796933 | ||
035 | |a (EPA)68541076 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a HAN YIPING |e verfasserin |4 aut | |
245 | 1 | 0 | |a METHODS FOR TREATING, PREVENTING AND DETECTING THE PROGNOSIS OF COLORECTAL CANCER |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2022-09-07, Last update posted on www.tib.eu: 2022-10-25, Last updated: 2023-02-09 | ||
520 | |a The present invention relates to treating cancer including colorectal cancer (CRC) by inhibiting or blocking Annexin 1. The present invention also relates to preventing CRC in a patient at high risk by inhibiting or blocking Annexin A1. The present invention also relates to reducing chemo-resistance by inhibiting or blocking Annexin A1. The present invention also relates to detecting a poor prognosis in a subject with CRC by detecting or measuring the expression level of ANXA1 and/or the level of Annexin 1 protein. | ||
650 | 4 | |a C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) | |
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a bio | |
650 | 4 | |a 615 | |
700 | 0 | |a DALERBA PIERO |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2022) vom: 07. Sept. |
773 | 1 | 8 | |g year:2022 |g day:07 |g month:09 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/68541076/publication/EP3796933A1?q=EP3796933 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
912 | |a SSG-OLC-PHA | ||
936 | u | w | |j 2022 |b 07 |c 09 |
951 | |a AR | ||
952 | |j 2022 |b 07 |c 09 |